Chinese Government Should Audit Investment In COVID-19 Vaccines And Medications – Analysis

Chinese Government Should Audit Investment In COVID-19 Vaccines And Medications – Analysis

Eurasia Review

Published

By He Jun

After three years of battle against COVID-19, when the Chinese government began to tweak its measures in November 2022 in response to the actual changes of the situation, China soon finds itself lack of medical resources.

Because of the spread of the contagious Omicron variant, there is the emergence of a large...

Full Article